首页
订购/客服:400-666-5481

INT-767

    
≥98%

INT-767

源叶(MedMol)
S81590 一键复制产品信息
1000403-03-1
C25H43NaO6S
494.6601
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S81590-1mg
≥98%

¥2300.00

货期:3-5天 - - - -
S81590-5mg
≥98%

¥7500.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: INT-767 is a dual farnesoid X receptor (FXR)/TGR5 agonist with mean EC50s of 30 and 630 nM, respectively
靶点: FXR;G protein-coupled Bile Acid Receptor 1;Autophagy;FXR; GPCR19
体外研究: INT-767 does not show cytotoxic effects in HepG2 cells, does not inhibit cytochrome P450 enzymes, is highly stable to phase I and II enzymatic modifications, and does not inhibit the human ether-a-go-go-related gene potassium channel
体内研究: INT-767 (10-20 mg/kg; i.p.; daily for 2 weeks) decreases plasma total cholesterol and triglyceride levels in db/m and db/db mice. Animal Model: Male 8-week old C57BKS/J db/db mice, control nondiabetic db/m mice Dosage: 10, 20 mg/kg Administration: Intraperitoneal injection; daily for 2 weeks Result: Decreased plasma total cholesterol and triglyceride levels.
参考文献: 1. Baghdasaryan A, et al. Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mousecholangiopathy model by promoting biliary HCO3- output. Hepatology. 2011 Oct;54(4):1303-1312. 2. Rizzo G, et al. Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor andTGR5 agonist. Mol Pharmacol. 2010 Oct;78(4):617-630.
溶解性: soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.022 ml 10.108 ml 20.216 ml
5 mM 0.404 ml 2.022 ml 4.043 ml
10 mM 0.202 ml 1.011 ml 2.022 ml
50 mM 0.04 ml 0.202 ml 0.404 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×